Overcoming Engineering Challenges to Enable Commercial Scale mRNA Vaccine Manufacturing: This article provides an overview of solutions to address key challenges facing vaccine developers or CDMOs wishing to build their own commercial-scale mRNA production facilities
| Publicado en: | Pharmaceutical Technology Vol. 46; no. 8; pp. 31 - 35 |
|---|---|
| Autores principales: | , , , |
| Formato: | pictorial tables/charts Journal Article |
| Publicado: |
MJH Life Sciences
Aug2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=158535880&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 158535880 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15432521 4FK jtl: Pharmaceutical Technology issn: 15432521 maglogo: N pubinfo: dt: Aug2022 vid: 46 iid: 8 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 158535880 158535880 158535880 158535880 ppf: 31 ppct: 4 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Overcoming Engineering Challenges to Enable Commercial Scale mRNA Vaccine Manufacturing: This article provides an overview of solutions to address key challenges facing vaccine developers or CDMOs wishing to build their own commercial-scale mRNA production facilities aug: au: Vickers, Julie Cramer, Peter Eardley-Patel, Ranna Excell, Oliver sug: subj: Vaccine Development Vaccines Manufacturing Industry Pharmaceutical Companies RNA, Messenger Biomedical Engineering Facility Design and Construction Chromatography Methods Nanoparticles Technology, Pharmaceutical pubtype: Trade Publication doctype: pictorial tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|